Document Report Card
Basic Information
ID: ALA1136797
Journal: J Med Chem
Title: Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Authors: Zhou G, Tsai CW, Liu JO.
Abstract: Fumagillin and ovalicin constitute a family of structurally related natural products that possess antiangiogenic activity. We report the synthesis of a new fumagillin analogue, fumagalone, in which the spiroepoxide group is replaced with an aldehyde. Fumagalone inhibits type 2 methionine aminopeptidase (MetAP2) with IC(50) = 8 microM and endothelial cell proliferation with IC(50) = 52 nM. With dialysis and competition assays, it was unambiguously demonstrated that binding of fumagalone to MetAP2 is reversible.
CiteXplore: 12877582
DOI: 10.1021/jm0341103